(205 days)
No
The document explicitly states "Mentions AI, DNN, or ML: Not Found" and the description focuses on 3D visualization and measurement, not AI/ML capabilities.
No
The device is a software interface for visualization of 3D data and performing measurements, intended to assist in evaluating and communicating treatment options, not to provide therapy itself.
No
The device is described as a software interface for visualizing 3D data and performing measurements to assist in evaluating and communicating treatment options. It is explicitly stated that it "should allow a clinician to evaluate and communicate about treatment options" and "is intended to be used in conjunction with other diagnostic tools." This indicates that it aids in the process but does not independently diagnose.
Yes
The device description explicitly states "SurgiCase Viewer is intended to be used as a software interface" and describes its functionality solely in terms of software operations (visualization, measurement, data import/export). The performance studies focus on software verification and validation, and comparisons are made to other software devices. There is no mention of any accompanying hardware component that is part of the regulated device.
Based on the provided information, SurgiCase Viewer is NOT an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is to "assist in visualization of treatment options" and "evaluate and communicate about treatment options." This focuses on visualizing and interacting with existing 3D data, not on performing tests on biological samples to diagnose or monitor a medical condition.
- Device Description: The description emphasizes visualization of 3D data, performing measurements on this data, and facilitating communication. It explicitly states that the device does not alter the 3D data it imports and its functioning is independent of the specific medical indication/situation.
- Lack of Biological Sample Analysis: IVD devices are specifically designed to perform tests on biological samples (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or screening. SurgiCase Viewer does not interact with biological samples in this way.
- Focus on Visualization and Measurement of 3D Models: The core function is to display and measure 3D models derived from medical images, which is a different purpose than analyzing biological samples.
While the device uses medical images as input and is used in a medical context, its function is related to processing and visualizing existing imaging data for treatment planning and communication, not for performing diagnostic tests on biological materials.
N/A
Intended Use / Indications for Use
SurgiCase Viewer is intended to be used as a software interface to assist in visualization of treatment options.
Product codes
LLZ
Device Description
SurgiCase Viewer provides functionality to allow visualization of 3D data and to perform measurements on these 3D data, which should allow a clinician to evaluate and communicate about treatment options.
SurgiCase Viewer is intended for use by people active in the medical sector. When used to review and validate treatment options, SurgiCase Viewer is intended to be used in conjunction with other diagnostic tools and expert clinical judgment.
The SurgiCase Viewer can be used by a medical device/service manufacturer/provider or hospital department to visualize 3D data during the manufacturing process of the product/service to the end-user who is ordering the device/service. This allows the end-user to evaluate and provide feedback on proposals or intermediate steps in the manufacturing of the device or service.
The SurgiCase Viewer is to be integrated with an online Medical Device Data System which is used to process the medical device or service and which is responsible for case management, user management, authorization, authentication, etc.
The data visualized in the SurgiCase Viewer is controlled by the medical device manufacturer using the SurgiCase Viewer in its process. The Device manufacturer will create the 3D data to be visualized to the end-user and export it to one of the dedicated formats supported by the SurgiCase Viewer. Each of these formats describe the 3D data in STL format with additional meta-data on the 3D models. The SurgiCase Viewer does not alter the 3D data it imports and its functioning is independent of the specific medical indication/situation or product/service it is used for. It's the responsibility of the Medical device company using the SurgiCase Viewer to comply with the applicable medical device regulations.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
medical sector
Medical device/service manufacturer/provider or hospital department
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Software verification and validation were performed and documentation was provided following the "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices". This includes verification against defined requirements, and validation against user needs with end-users.
The SurgiCase Viewer application has been validated for its intended use to determine substantial equivalence to the primary predicate device SurgiCase Viewer.
The medical images functionality was compared to the same functionality present in the secondary reference device Mimics. Both functionality produce the same results in:
- Contrast adjustments
- Interactive image reslicing
- 3D contour overlay on images
Measurement functionality on images was compared with already existing functionality on the 3D models and shown to provide correct results both on images and 3D.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, with the word "ADMINISTRATION" underneath. The logo is simple and professional, and it is easily recognizable.
Materialise NV % Aya Nishikawa Regulatory Affairs Specialist Technologielaan 15 Leuven, 3001 BELGIUM
Re: K213684
June 15, 2022
Trade/Device Name: SurgiCase Viewer Regulation Number: 21 CFR 892.2050 Regulation Name: Medical image management and processing system Regulatory Class: Class II Product Code: LLZ Dated: May 6, 2022 Received: May 9, 2022
Dear Aya Nishikawa:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for
1
devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Jessica Lamb. Ph.D. Assistant Director Imaging Software Team DHT8B: Division of Radiological Imaging Devices and Electronic Products OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K213684
Device Name SurgiCase Viewer
Indications for Use (Describe)
SurgiCase Viewer is intended to be used as a software interface to assist in visualization of treatment options.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary
The following section is included as required by the Safe Medical Devices Act (SMDA) of 1990 and 21CFR 807.92
| Company name | Materialise N.V. |
|---|---|
| Establishment registration number | 3003998208 |
| Street Address | Technologielaan 15 |
| City | Leuven |
| Postal code | 3001 |
| Country | Belgium |
| Phone number | +32 16 39 66 11 |
| Fax number | +32 16 39 66 06 |
| Principal Contact person | Aya Nishikawa |
| Contact title | Regulatory Affairs Specialist |
| Contact e-mail address | Regulatory.Affairs@materialise.be |
| Additional contact person | Anneleen Van Assche |
| Contact title | Software Product Manager |
| Contact e-mail address | Anneleen.VanAssche@materialise.be |
Submission date
The date of the Traditional 510(k) submission is November 16th, 2021 Updated: April 25th, 2022
Submission information
| Trade Name | SurgiCase Viewer
Materialise Viewer |
|-----------------------------|----------------------------------------|
| Common Name | Image processing system |
| Classification Name | System, Image processing, Radiological |
| Classification product code | LLZ (21 CFR 892.2050) |
Predicate Devices
The primary predicate devices to which substantial equivalence is claimed:
4
| Trade or proprietary or model name | SurgiCase Viewer |
|---|---|
| 510(k) number | K170419 |
| Decision date | May 11, 2017 |
| Classification product code | LLZ (21 CFR 892.2050) |
| Manufacturer | Materialise N.V. |
The secondary reference device:
| Trade or proprietary or model name | Mimics Medical |
|---|---|
| 510(k) number | K183105 |
| Decision date | March 27, 2019 |
| Classification product code | LLZ (21 CFR 892.2050) |
| Manufacturer | Materialise N.V. |
Description and functioning of the device
SurgiCase Viewer provides functionality to allow visualization of 3D data and to perform measurements on these 3D data, which should allow a clinician to evaluate and communicate about treatment options.
SurgiCase Viewer is intended for use by people active in the medical sector. When used to review and validate treatment options, SurgiCase Viewer is intended to be used in conjunction with other diagnostic tools and expert clinical judgment.
The SurgiCase Viewer can be used by a medical device/service manufacturer/provider or hospital department to visualize 3D data during the manufacturing process of the product/service to the end-user who is ordering the device/service. This allows the end-user to evaluate and provide feedback on proposals or intermediate steps in the manufacturing of the device or service.
The SurgiCase Viewer is to be integrated with an online Medical Device Data System which is used to process the medical device or service and which is responsible for case management, user management, authorization, authentication, etc.
The data visualized in the SurgiCase Viewer is controlled by the medical device manufacturer using the SurgiCase Viewer in its process. The Device manufacturer will create the 3D data to be visualized to the end-user and export it to one of the dedicated formats supported by the SurgiCase Viewer. Each of these formats describe the 3D data in STL format with additional meta-data on the 3D models. The SurgiCase Viewer does not alter the 3D data it imports and its functioning is independent of the specific medical indication/situation or product/service it is used for. It's the responsibility of the Medical device company using the SurgiCase Viewer to comply with the applicable medical device regulations.
5
Intended Use
SurgiCase Viewer is intended to be used as a software interface to assist in visualization of treatment options.
Comparison of Technological Characteristics with the Predicate Device
A detailed comparison shows the subject device is substantially equivalent in intended use, design, functionality, operating principles, materials and performance characteristics to the primary predicate devices.
The subject device SurgiCase Viewer is equivalent to the predicate device SurgiCase Viewer (K170419) in:
- . Intended use: Both the subject device as well as the predicate device have the same intended use;
- O They are both intended to be used as a software interface to assist in visualization and communication of treatment options.
- Device functionality:
- Import plans from dedicated file formats O
- O 3D view navigation: updating camera orientation/zooming/panning
- o Visualization options:
- show/hide, transparency of objects, primitives, measurements
- . ability to visualize predefined views (a view is a preset collection of models/images which are visualized together) optionally including questions to be answered by the end-user
- . clipping of 3D models
- Measuring O
- O Making indications/annotations on the 3D models
- Device architecture/technology: SurgiCase Viewer shares the same architecture/technology and functionality as the primary predicate device, however, functionality was just further extended to improve the usability for the user.
- Device design and development process: Both predicate and subject software are manufactured by the same company (Materialise NV), the subject device originates from the same code base as the predicate device; and follows the same development cycle and testing procedures as the predicate device. The verification and validation of predicate and subject device has been done following the same procedures and workflows.
The main differences between the subject and the predicate device are:
- Device Functionality: the subject's device functionality was further extended from the predicate device's functionality with:
- O Medical images visualization
- . Including image scrolling, zooming, panning
- l Contrast adjustments
- l Interactive image reslicing
- 3D contour overlay on images
- o Visualization of 3D models in Virtual Reality
- O Medical images visualization
6
The abovementioned technological differences do not impact the safety and effectiveness of the subject device for the proposed intended use as is demonstrated by the verification and validation plan.
The subject device SurgiCase Viewer is substantially equivalent to the secondary reference device Mimics Medical (K183105) in:
- . Device Functionality
- o Medical images visualization
- Including image scrolling, zooming, panning
- Contrast adjustments
- . Interactive image reslicing
- 3D contour overlay on images
- o Medical images visualization
- Device design and development process: Both reference and subject software are manufactured by the same company (Materialise NV), the subject device originates from the same code base as the reference device; and follows the same development cycle and testing procedures as the predicate device. The verification and validation of predicate and subject device has been done following the same procedures and workflows.
Differences in technological characteristics of the subject device compared with the reference device Mimics Medical:
- . Intended use: While the subject device SurgiCase Viewer is intended to be used as a software interface to assist in visualization and communication of treatment options, the reference device Mimics Medical is also intended as an image segmentation system and intended for treatment planning.
- Device Functionality:
- O the reference device functionality is much more extended than the subject device, which only includes a limited subset of functionality from the reference device, due to its different intended use.
- Device architecture/technology: while the reference device Mimics Medical is a Windows based desktop solution, the subject device is a web application which can be used in different browsers and on different operating systems (however the underlying libraries used for image based operations are still the same in both products).
The above mentioned technological differences do not impact the safety and effectiveness of the subject device for the proposed intended use as is demonstrated by the verification and validation plan.
Performance Data
Software verification and validation were performed and documentation was provided following the "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices". This includes verification against defined requirements, and validation against user needs with end-users.
The SurgiCase Viewer application has been validated for its intended use to determine substantial equivalence to the primary predicate device SurgiCase Viewer.
The medical images functionality was compared to the same functionality present in the secondary reference device Mimics. Both functionality produce the same results in:
- Contrast adjustments
- . Interactive image reslicing
7
- . 3D contour overlay on images
Measurement functionality on images was compared with already existing functionality on the 3D models and shown to provide correct results both on images and 3D.
Summary
The characteristics that determine the functionality and performance of the surgiCase Viewer are substantially equivalent to the devices cleared under K170419 and K183105. The non-clinical testing indicates that the subject device is as safe, as effective, and performs as well as the predicates.
From the substantial equivalence analysis we conclude that the intended use and technological characteristics of SurgiCase Viewer are substantially equivalent to a combination of the predicate device SurgiCase Viewer (K170419) and the reference device Mimics Medical (K183105). Based on the application of risk management and performance testing we conclude that SurgiCase Viewer is as safe and effective as its predicate and reference devices and does not raise any new issues related to safety and effectiveness compared to the predicate and reference devices, and has a comparable performance.